Ionis Neurology: Pipeline The content on this page is intended for use by US healthcare professionals only. Ionis continues to build upon its pioneering platform and foundational knowledge to develop medicines that can alter disease trajectory.1-4 Transforming Genomic Insights Into RNA-Targeted Innovation Ionis’ RNA-targeted technology translates genomics insights into potential transformative medicines.5 Once a causative […]

What’s Next: Innovation In Neurology The content on this page is intended for use by US healthcare professionals only. Transforming the Management of Neurologic Diseases Discovering new approaches to manage neurologic diseases can be especially challenging. The current challenges with drug development leave significant unmet clinical needs among these patients.1 Ionis is committed to discovering, […]

What’s Next: Innovation In Neurology The content on this page is intended for use by US healthcare professionals only. RNA-Targeted Regulation of Proteins There are different classes of RNA-targeted medicines, including antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs).1 ASOs are single-strand oligonucleotides that bind directly to their mRNA target to upregulate or downregulate protein […]

Ionis Neurology: Community Connection The content on this page is intended for use by US healthcare professionals only. We are committed to addressing the significant unmet needs across a spectrum of neurologic diseases.1-3 A Leader in the Neurology Community Ionis provides scholarships for individuals affected by neurologic diseases and funds grants to support physicians and […]